Cargando…

Correction Notice: Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Correction Notice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629333/ https://www.ncbi.nlm.nih.gov/pubmed/34859196 http://dx.doi.org/10.1097/HS9.0000000000000659

Ejemplares similares

Correction Notice: Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
Publicado: (2021)

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
por: Dimopoulos, Meletios A., et al.
Publicado: (2021)

Correction Notice: The EHA Research Roadmap: Anemias
Publicado: (2021)

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Waldenström’s Macroglobulinemia
por: Staber, Philipp B., et al.
Publicado: (2021)

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes
por: van de Loosdrecht, Arjan A., et al.
Publicado: (2022)

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up of Chronic Lymphocytic Leukemia
por: Eichhorst, Barbara, et al.
Publicado: (2020)

EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas
por: Ladetto, Marco, et al.
Publicado: (2020)

EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma
por: Ladetto, Marco, et al.
Publicado: (2021)

Correction Notice: Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges? Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
Publicado: (2022)

Correction Notice: Measurable Residual Disease Testing in Multiple Myeloma Routine Clinical Practice: A Modified Delphi Study
Publicado: (2023)

EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma
por: Linton, Kim, et al.
Publicado: (2020)

Correction Notice: Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma
Publicado: (2023)

EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic
por: Dreyling, Martin, et al.
Publicado: (2021)

Correction Notice
Publicado: (2017)

Correction Notice
Publicado: (2017)

Correction Notice
Publicado: (2019)

Correction Notice
Publicado: (2022)

Correction notice
Publicado: (2022)

Correction notice
Publicado: (2022)

Correction Notice—The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action
Publicado: (2023)

Reply to Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
por: Bracale, Umberto, et al.
Publicado: (2016)

EHA evaluation of the ESMO—Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies
por: Kiesewetter, Barbara, et al.
Publicado: (2020)

Correction Notice: Low-risk Essential Thrombocythemia: A Comprehensive Review
Publicado: (2022)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer
por: Kanesvaran, R., et al.
Publicado: (2022)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer
por: Koppikar, S., et al.
Publicado: (2023)

Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
por: Le Rhun, E., et al.
Publicado: (2023)

Correction Notice: Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALL
Publicado: (2023)

Correction notice to: The effect of nigella sativa oil on the prevention of phlebitis induced by chemotherapy: a clinical trial
por: Behnamfar, Niaz, et al.
Publicado: (2019)

Correction Notice: Cytokine Profiling as a Novel Complementary Tool to Predict Prognosis in MPNs?
Publicado: (2020)

Correction Notice to: Surgical videos on the internet: Is this a reliable pedagogical tool in residency training?
por: Ghersi, Abdelhamid, et al.
Publicado: (2022)

Correction Notice: Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A
Publicado: (2022)

Correction Notice: Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm
Publicado: (2021)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma
por: Kanesvaran, R., et al.
Publicado: (2021)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer
por: Yoshino, T., et al.
Publicado: (2023)

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
por: Buske, C., et al.
Publicado: (2022)

Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment(†)
por: Santini, D, et al.
Publicado: (2020)

Correction Notice – Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study
Publicado: (2023)

Notices
Publicado: (2009)

Notice
Publicado: (2013)

Notice
por: Fitch, T. D.
Publicado: (1871)

Cannot write session to /tmp/vufind_sessions/sess_jne5g4hsji66dmv2odlpj6qbm8